stella
beta
Adapted Guided Stereotactic Body Radiotherapy Combined with Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND) — Stella
Recruiting
Back to Pancreatic Cancer trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Shandong Cancer Hospital and Institute, Jinan, Shandong
View full record on ClinicalTrials.gov